Search
Idazoxan
go.drugbank.com/drugs/DB12551InvestigationalIdazoxan has been used in trials studying the basic science of Molecular Imaging, Alzheimer Disease, and Major Depressive Disorder.
Icaritin
go.drugbank.com/drugs/DB12672InvestigationalIcaritin has been used in trials studying the treatment of Solid Tumors, Metastatic Breast Cancer, and Hepatocellular Carcinoma (HCC).
Felcisetrag
go.drugbank.com/drugs/DB12725InvestigationalFelcisetrag (TD-8954) has been used in trials studying the treatment of Enteral Feeding Intolerance and Gastrointestinal Motility Disorder.
SX-682
go.drugbank.com/drugs/DB19210InvestigationalSX-682 is under investigation in clinical trial NCT04574583 (Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With Bintrafusp … Alfa (M7824 or Tgf-beta "Trap"/pd-l1) With CV301 TRICOM in Advanced Solid Tumors (STAT)).
FB-825
go.drugbank.com/drugs/DB17598InvestigationalFB-825 is an investigational humanized monoclonal antibody that targets the CεmX domain of the membrane-bound IgE (mIgE), causing a depletion of mIgE positive B-cells. … It is currently being investigated for immune disorders, such as atopic dermatitis and hyperimmunoglobulin E syndrome (HIES).[A258448,L45743]
ISB 1442
go.drugbank.com/drugs/DB18475InvestigationalISB 1442 is a bispecific, biparatopic antibody targeting CD38 and CD47
NVS antibody
go.drugbank.com/drugs/DB05312ExperimentalThis drug has been developed using Medarex's UltiMAb Human Antibody Development System to treat autoimmune diseases.
Nordazepam
go.drugbank.com/drugs/DB14028InvestigationalAn intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam.
Categories: Amino Acids, Peptides, and Proteins, Benzodiazepines and benzodiazepine derivativesSynonyms: N-desmethyldiazepamFulacimstat
go.drugbank.com/drugs/DB15085InvestigationalFulacimstat is under investigation in clinical trial NCT02452515 (A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With